Health Atlas
Menu
Evidence-led reference

Movement & fitness

Hyperbaric oxygen: medical uses, wellness chambers, and aging claims

6 sources · Latest source check 2026-10-07 UTC
On this page

Hyperbaric oxygen therapy involves breathing oxygen in a chamber at pressure above ordinary atmospheric pressure. Clinical protocols specify pressure, oxygen delivery, exposure and medical indication. Low-pressure “mild” or wellness chambers are not automatically equivalent to the systems and regimens studied for clinical treatment.[1]

Three different questions

Three different questions
ContextWhat is being claimed
Established medical indicationsExamples include decompression illness, gas embolism and selected radiation injuries or problem wounds. Evaluation is indication-specific.[1]
Commercial disease claimsFDA warns about unapproved claims covering conditions such as Alzheimer’s disease, autism, Lyme disease or cancer treatment.[3]
Healthy agingChanging telomere or senescent-cell measurements is not equivalent to preventing disability or extending lifespan.[5]

Why a medical use still needs a defined population

A 2015 Cochrane wound review included 12 trials with 577 participants. In diabetic foot ulcers, pooled trials suggested better short-term healing, but that benefit was not evident at one year. The review described design and reporting limitations and inadequate harm reporting. This dated review does not settle every wound type or all evidence available in 2026.[4]

A claim about wound healing should specify the wound, background treatment, comparator and follow-up. Improvement in a selected clinical context cannot be transferred to every persistent symptom or to healthy users. The older Cochrane review is useful for understanding these boundaries, not as a complete current treatment guideline.[4]

What the telomere study actually measured

The 2020 study enrolled 35 older adults, of whom 30 completed treatment; blood analyses used smaller subsets. It reported changes in telomere length and senescence-related markers in certain immune-cell populations after repeated sessions. There was no randomized or sham control. Assessments shortly after treatment do not establish how long changes last, whether they prevent disease or whether people live longer.[5]

Some authors disclosed employment or shareholding in a commercial hyperbaric company. Those disclosures matter when judging independence; they do not by themselves invalidate a finding. The more direct limitations are the small sample, absent control and surrogate outcomes.[5]

Pressure, adverse events, and fire

A 2023 safety meta-analysis included 24 randomized trials with 1,497 participants. Adverse effects were more frequent in HBOT groups, and ear discomfort was the most commonly reported event. The included illnesses, protocols and controls varied. Its pooled rates should not be treated as the exact personal risk for every chamber or indication.[6]

The review also found differences associated with treatment pressure and course length. These study-level findings do not establish a universally safe home setting or schedule. Safety assessment requires the actual equipment, clinical circumstances and supervision; “lower pressure” is not proof of equivalent benefit or zero risk.[6]

In August 2025, FDA highlighted reported chamber fires causing serious injuries and deaths; the root causes were not yet determined. It emphasized manufacturer instructions, training, maintenance, grounding and controls on incompatible materials. Rare serious events can still matter when benefit is uncertain.[2]

A cleared chamber is not every advertised treatment

FDA describes HBOT devices as class II devices cleared through the 510(k) pathway. That regulatory status does not validate every condition advertised by a clinic. FDA’s consumer bulletin warns against unsupported disease claims and encourages discussing treatment with a qualified professional.[2][3]

Evidence & uncertainty

Selected medical uses and broad anti-aging claims require separate evidence. An often-cited aging study measured blood-cell markers without a comparison group; it did not establish longer life or better daily functioning. Device clearance and changes in a laboratory marker cannot settle those clinical questions.[5]

Selected-source overview · Independent review pending

Published questions

Are low-pressure wellness chambers automatically equivalent to medical HBOT?

Selected-source overview · Independent review pending. Read the evidence context.

No. Pressure, oxygen delivery and protocol can differ. Evidence for a specified medical treatment does not transfer automatically to a different chamber.[1]

Evidence behind this answer
  • Hyperbaric Oxygen Therapy Indications

    professional indications and definition · Date not stated
    Indexed original-source passages inspected; direct retrieval blocked · Definition, medical indications and distinction from low-pressure mild hyperbaric exposure

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does a recognized HBOT medical use establish benefit for every wellness claim?

Selected-source overview · Independent review pending. Read the evidence context.

No. Indications are specific. A decompression or wound-care use does not establish treatment of unrelated diseases or general rejuvenation.[1]

Evidence behind this answer
  • Hyperbaric Oxygen Therapy Indications

    professional indications and definition · Date not stated
    Indexed original-source passages inspected; direct retrieval blocked · Definition, medical indications and distinction from low-pressure mild hyperbaric exposure

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does the hyperbaric telomere study prove that people live longer?

Selected-source overview · Independent review pending. Read the evidence context.

No. It was a small uncontrolled study of blood-cell markers, with short post-treatment assessment. It did not establish lifespan or functional benefit.[5]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does the cited wound review establish a lasting benefit for every chronic wound?

Selected-source overview · Independent review pending. Read the evidence context.

No. Its findings varied by wound and follow-up, with design and reporting limitations. It searched through 2015 and is not a complete current synthesis.[4]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Is a hyperbaric chamber free from serious safety risks?

Selected-source overview · Independent review pending. Read the evidence context.

No. FDA reported fires with serious injuries and deaths. Trial evidence also includes adverse effects such as ear discomfort; equipment and supervision matter.[2]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does chamber clearance validate claims about Alzheimer’s disease, autism, or Lyme disease?

Selected-source overview · Independent review pending. Read the evidence context.

No. FDA’s consumer bulletin specifically warns about unapproved claims for these conditions. A device’s regulatory status does not establish every marketed use.[3]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

The remaining appraisal

Each medical indication needs its own current comparative review. This page does not recommend purchasing a chamber, selecting exposure settings or changing established treatment. Durable healthy-aging benefits remain a separate unresolved question.

References

  1. Hyperbaric Oxygen Therapy Indications

    Professional indications and definition

    Undersea and Hyperbaric Medical Society · Content/publication date: not stated
    Accessed: 2026-10-07 UTC · Indexed original-source passages inspected; direct retrieval blocked
    Cited sections: Definition, medical indications and distinction from low-pressure mild hyperbaric exposure

    Official indexed passages inspected; direct page returned 406. No publication year inferred from the edition or site header.

  2. Follow Instructions for Safe Use of Hyperbaric Oxygen Therapy Devices

    Regulatory safety notice

    FDA · Content/publication date: 2025
    Accessed: 2026-10-07 UTC · Selected relevant page text or original publication abstract inspected
    Cited sections: August 2025 fires, serious injuries/deaths, undetermined causes and equipment safeguards

  3. FDA Consumer Update: Hyperbaric Oxygen Therapy — Get the Facts

    Agency consumer bulletin

    FDA · Content/publication date: 2021
    Accessed: 2026-10-07 UTC · Selected relevant page text or original publication abstract inspected
    Cited sections: FDA’s July 2021 bulletin: misleading disease claims and accredited care

    The official FDA-distributed bulletin was inspected. Its linked consumer page returned 404 during this check, so the available bulletin is cited directly.

  4. Hyperbaric oxygen therapy for treating chronic wounds

    Systematic review

    Kranke P and colleagues; Cochrane · Content/publication date: 2015
    Accessed: 2026-10-07 UTC · Selected relevant page text or original publication abstract inspected
    Cited sections: 12 trials, 577 participants; short/one-year diabetic-foot outcomes and limitations

    Review searched through February 2015. Historical selected findings; not represented as a comprehensive 2026 indication review.

  5. Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial

    Uncontrolled prospective study

    Hachmo Y and colleagues · Content/publication date: 2020
    Accessed: 2026-10-07 UTC · Selected relevant page text or original publication abstract inspected
    Cited sections: Methods, results, short post-treatment sampling, subset exclusions and competing interests

    Original full article inspected. It enrolled 35, with 30 completing treatment. Telomere exclusion text and a table sample count are inconsistent, so no precise telomere-analysis sample is asserted here. No control group; no lifespan outcome.

  6. Adverse effects of hyperbaric oxygen therapy: a systematic review and meta-analysis

    Systematic review and meta analysis

    Zhang Y and colleagues · Content/publication date: 2023
    Accessed: 2026-10-07 UTC · Selected relevant page text or original publication abstract inspected
    Cited sections: Abstract: 24 RCTs, 1,497 participants, adverse effects, ear discomfort and protocol differences

    Search covered March 2012–October 2022. Selected original abstract inspected; pooled subgroup patterns do not supply a universally safe schedule.

Scope & review

Population
Indication-specific clinical populations; older-adult uncontrolled aging study distinguished
Exposure or intervention
Pressurized oxygen with device- and regimen-specific parameters
Comparison
Clinical trial controls; aging study had no comparison group
Outcomes
Clinical healing, adverse events and functioning distinguished from blood-cell surrogates
Timeframe
2015 wound search; 2023 safety review searched through 2022; FDA safety notice 2025
Jurisdiction
US FDA/UHMS and international trials; recognized uses and regulation vary

Targeted educational explanation from selected official sources, original guidelines and primary publications. Not an exhaustive systematic review, individualized treatment plan or qualified medical signoff.

Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.

Revision history
  • 2026-10-07 UTC: Added definitions, categories, evidence comparisons, harms, applicability limits and sourced reader questions. Qualified review remains pending.

What this article still leaves open

  • Current patient-important benefits and harms for each individual medical indication.
  • Controlled healthy-aging trials, durable clinical outcomes and device-specific applicability.
Suggest a correction

Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.

Explore the topic map

Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.